Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure
GH Bardy, KL Lee, DB Mark, JE Poole… - … England Journal of …, 2005 - Mass Medical Soc
… cardiac causes remains a leading cause of death among patients with congestive heart failure
(… Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD) has been …
(… Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD) has been …
Implantable cardioverter defibrillators and their role in heart failure progression
C Cevik, A Perez-Verdia, K Nugent - Europace, 2009 - academic.oup.com
… directly affect the myocardium and increase cardiac dysfunction. Most patients with heart
failure have a history of myocardial infarction (MI) as the aetiology of their heart failure. Post-MI …
failure have a history of myocardial infarction (MI) as the aetiology of their heart failure. Post-MI …
… disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart …
WT Abraham, JB Young, AR León, S Adler, AJ Bank… - Circulation, 2004 - Am Heart Assoc
… CRT significantly improves cardiac structure and function … treated patients with mildly
symptomatic NYHA class II heart failure… study demonstrating that heart failure patients with …
symptomatic NYHA class II heart failure… study demonstrating that heart failure patients with …
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from …
DJ van Veldhuisen, AH Maass, SG Priori… - … of heart failure, 2009 - Wiley Online Library
… Chronic heart failure (HF) remains a large medical and epidemiological problem.1 …
cardioverter defibrillator (ICD) and the biventricular pacemaker, generally referred to as cardiac …
cardioverter defibrillator (ICD) and the biventricular pacemaker, generally referred to as cardiac …
Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis
JT Vehmeijer, TF Brouwer, J Limpens… - European heart …, 2016 - academic.oup.com
… 3% in 3.6 years, respectively, 5 most likely due to more severe heart failure and general
condition. However, mortality rates were much lower than in the conventional ICD population of …
condition. However, mortality rates were much lower than in the conventional ICD population of …
Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure
MB Elming, JC Nielsen, J Haarbo, L Videbæk… - Circulation, 2017 - Am Heart Assoc
… bradycardia, or complete heart block; it cannot provide protection against other causes of …
patients with heart failure change with age. Younger patients may be more prone to ventricular …
patients with heart failure change with age. Younger patients may be more prone to ventricular …
Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics
ME Alexander, F Cecchin, EP Walsh… - … of cardiovascular …, 2004 - Wiley Online Library
… and adult survivors of congenital heart disease (CHD) 1 and a … patients with cardiomyopathy
and primary electrical disease. The experience with implantable cardioverter defibrillators (…
and primary electrical disease. The experience with implantable cardioverter defibrillators (…
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial
JB Young, WT Abraham, AL Smith, AR Leon… - Jama, 2003 - jamanetwork.com
… Cardiac resynchronization improved quality of life, functional status, and exercise capacity in
patients with moderate to severe HF, … who have chronic heart failure (HF) also have cardiac …
patients with moderate to severe HF, … who have chronic heart failure (HF) also have cardiac …
… cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure …
DL Packer, JM Prutkin, AS Hellkamp, LB Mitchell… - Circulation, 2009 - Am Heart Assoc
… Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac
defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. …
defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. …
The implantable cardioverter defibrillator
M Glikson, PA Friedman - The Lancet, 2001 - thelancet.com
… In addition to treating ventricular tachyarrhythmias, new defibrillators provide full featured
dual chamber pacing, and could treat atrial arrhythmias, and congestive heart failure by means …
dual chamber pacing, and could treat atrial arrhythmias, and congestive heart failure by means …
相关搜索
- patients with congestive heart failure
- chronic heart failure implantable cardioverter defibrillator
- chronic heart failure cardiac resynchronization therapy
- severe heart failure amiodarone mortality reduction
- severe congestive heart failure randomised trial
- congenital heart disease
- sudden cardiac death heart failure trial
- cardioverter defibrillators primary prevention
- patients with nonischemic systolic heart failure
- heart failure meta analysis
- congestive heart failure asymptomatic ventricular arrhythmia
- congestive heart failure effect of amiodarone
- congestive heart failure clinical status
- chronic heart failure left ventricular size
- implantable cardioverter defibrillator therapy